Compass Diversified Declares Second Quarter 2024 Distributions on Common and Series A, B and C Preferred Shares
WESTPORT, Conn., July 02, 2024 (GLOBE NEWSWIRE) — Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading […]
Employers Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call
HENDERSON, Nev., July 02, 2024 (GLOBE NEWSWIRE) — Employers Holdings, Inc. (the “Company”) (NYSE:EIG) today announced that it will release its […]
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
MIAMI, July 02, 2024 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) declares its monthly distribution for July […]
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
— Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History — — Signed $30 Million in Net […]
Cipher Mining Announces June 2024 Operational Update
NEW YORK, July 02, 2024 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today released its unaudited […]
Exponent to Announce Second Quarter of Fiscal Year 2024 Results and Host Quarterly Conference Call on July 25, 2024
MENLO PARK, Calif., July 02, 2024 (GLOBE NEWSWIRE) — Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second […]
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
IRVINE, Calif., July 02, 2024 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the Company’s management team […]
Actelis Announces Closing of Exercise of Warrants for $2.25 Million Gross Proceeds
FREMONT, Calif., July 02, 2024 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in […]
Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) — Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical […]
BrightSpring Health Services, Inc. to Announce Second Quarter 2024 Financial Results on August 2, 2024
LOUISVILLE, Ky., July 02, 2024 (GLOBE NEWSWIRE) — BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today […]
